Viruses are the leading cause of respiratory infections in children and adults and are a major cause of morbidity and mortality worldwide. Respiratory viral infections contribute to be leading cause of morbidity, mortality, and economic loss throughout the world.1) Respiratory syncytial virus (RSV) is a major cause of pneumonia and bronchiolitis in infants, in children, and even in adults.2) Ribavirin and immunoglobulin preparations with high titers of RSV-specific neutralizing antibodies are currently approved for use to treat and prevent RSV infections. However, neither of these is cost-effective and simple to administer.3) Parainfluenza type 3 virus (PIV 3) is another respiratory virus caused infections in children. No chemotherapy agents and vaccine have been used to treat PIV 3 infections. 4) Therefore, the development of new antiviral agents with different mechanisms is most desirable. Traditional medicines utilizing natural products have been shown to contain antiviral compounds. [5][6][7][8][9] The screening of plants as a possible source of antiviral has led to the discovery of potent inhibitors of in vitro viral growth and the use of the ethnopharmacological approach enhances the probability of identifying new bioactive plant compounds.
10)Our interest has focused on the treatments for respiratory viral infections. In order to find more potent inhibitors of RSV and PIV 3, we have been looking for some inhibitory substances from natural sources.
11-17)Selaginella uncinata SPRING is a Chinese herb medicine widely distributed in south China, which has been used to treat infectious diseases and tumors. Previous phytochemical studies on the constituents of genus Selaginella led to the discovery of many compounds, including flavonoids and lignans. 18,19) As part of our continuous searching for novel antivial agents from medicinal plants, ethanol extract of the whole plants of S. uncinata was found to show significant inhibitory activities against RSV. The active extract led to the isolation and characterization of two new compounds, named uncinoside A (1) and uncinoside B (2) 20) together with three known compounds. Here we report the isolation and structure elucidation of the two new chromone glycosides and their antiviral activities against RSV, PIV 3, and influenza type A virus (Flu A).
Results and DiscussionAn EtOH extract of the whole plant of S. uncinata was concentrated and partitioned with CHCl 3 and EtOAc. The CHCl 3 fraction was separated by silica gel column chromatography to yield two new chromone glycosides uncinoside A (1) and uncinoside B (2), and one known 5,7-dihydroxy-2,6-8-trimethylchromone (8-methyleugenitol) (3). The EtOAc fraction was separated by silica gel and polyamide column chromatography and prepared thin-layer chromatography (TLC) to afford two known biflavonoids: amentoflavone (4) 11,21) and hinokiflavone (5) 21,22) (Chart 1). The structure of the compound 3 was determined by the Xray diffraction analysis and spectral data. The structures of the other two known biflavonoids were...